aluates Reports

$ 0.0

Automative

Global Plasma Protease C1-inhibitor Treatment Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-5D6187

Global Plasma Protease C1 inhibitor Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Plasma Protease C1-inhibitor Treatment Market Research Report 2025

Code: QYRE-Auto-5D6187

Report

September 2025

Pages:60

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Plasma Protease C1-inhibitor Treatment Market Size

The global market for Plasma Protease C1-inhibitor Treatment was valued at US$ 2478 million in the year 2024 and is projected to reach a revised size of US$ 3852 million by 2031, growing at a CAGR of 6.6% during the forecast period.

Plasma Protease C1-inhibitor Treatment Market

This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising pipeline drugs and novel therapies, rising investments in innovation of inhibitor drugs and increasing HAE awareness programs are the major drivers of the global plasma protease C1-inhibitors treatment market.

Based on drug class, the market has been segmented into C1-inhibitors (C1-esterase Inhibitor, Recombinant Inhibitor); Kallikrein Inhibitor (Kalbitor); Selective Bradykinin B2 Receptor Antagonist (Firazyr). The drug class market segments have been analyzed based on available approved products, cost-effectiveness, and preference given by the physicians for the treatment of HAE patients.

This report aims to provide a comprehensive presentation of the global market for Plasma Protease C1-inhibitor Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma Protease C1-inhibitor Treatment.

The Plasma Protease C1-inhibitor Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plasma Protease C1-inhibitor Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Plasma Protease C1-inhibitor Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Plasma Protease C1-inhibitor Treatment Market Report

Report Metric	Details
Report Name	Plasma Protease C1-inhibitor Treatment Market
Accounted market size in year	US$ 2478 million
Forecasted market size in 2031	US$ 3852 million
CAGR	6.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	C1-inhibitors Kallikrein Inhibitor (Kalbitor)
Segment by Application	Hospital Pharmacies Independent Pharmacies and Outlets
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda, CSL, Sanquin, Pharming Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasma Protease C1-inhibitor Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Plasma Protease C1-inhibitor Treatment Market growing?

Ans: The Plasma Protease C1-inhibitor Treatment Market witnessing a CAGR of 6.6% during the forecast period 2025-2031.

What is the Plasma Protease C1-inhibitor Treatment Market size in 2031?

Ans: The Plasma Protease C1-inhibitor Treatment Market size in 2031 will be US$ 3852 million.

Who are the main players in the Plasma Protease C1-inhibitor Treatment Market report?

Ans: The main players in the Plasma Protease C1-inhibitor Treatment Market are Takeda, CSL, Sanquin, Pharming Group

What are the Application segmentation covered in the Plasma Protease C1-inhibitor Treatment Market report?

Ans: The Applications covered in the Plasma Protease C1-inhibitor Treatment Market report are Hospital Pharmacies, Independent Pharmacies and Outlets

What are the Type segmentation covered in the Plasma Protease C1-inhibitor Treatment Market report?

Ans: The Types covered in the Plasma Protease C1-inhibitor Treatment Market report are C1-inhibitors, Kallikrein Inhibitor (Kalbitor)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 C1-inhibitors

1.2.3 Kallikrein Inhibitor (Kalbitor)

1.3 Market by Application

1.3.1 Global Plasma Protease C1-inhibitor Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Independent Pharmacies and Outlets

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Plasma Protease C1-inhibitor Treatment Market Perspective (2020-2031)

2.2 Global Plasma Protease C1-inhibitor Treatment Growth Trends by Region

2.2.1 Global Plasma Protease C1-inhibitor Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Plasma Protease C1-inhibitor Treatment Historic Market Size by Region (2020-2025)

2.2.3 Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Region (2026-2031)

2.3 Plasma Protease C1-inhibitor Treatment Market Dynamics

2.3.1 Plasma Protease C1-inhibitor Treatment Industry Trends

2.3.2 Plasma Protease C1-inhibitor Treatment Market Drivers

2.3.3 Plasma Protease C1-inhibitor Treatment Market Challenges

2.3.4 Plasma Protease C1-inhibitor Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Plasma Protease C1-inhibitor Treatment Players by Revenue

3.1.1 Global Top Plasma Protease C1-inhibitor Treatment Players by Revenue (2020-2025)

3.1.2 Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Plasma Protease C1-inhibitor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Plasma Protease C1-inhibitor Treatment Revenue

3.4 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio

3.4.1 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Plasma Protease C1-inhibitor Treatment Revenue in 2024

3.5 Global Key Players of Plasma Protease C1-inhibitor Treatment Head office and Area Served

3.6 Global Key Players of Plasma Protease C1-inhibitor Treatment, Product and Application

3.7 Global Key Players of Plasma Protease C1-inhibitor Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Plasma Protease C1-inhibitor Treatment Breakdown Data by Type

4.1 Global Plasma Protease C1-inhibitor Treatment Historic Market Size by Type (2020-2025)

4.2 Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Type (2026-2031)

5 Plasma Protease C1-inhibitor Treatment Breakdown Data by Application

5.1 Global Plasma Protease C1-inhibitor Treatment Historic Market Size by Application (2020-2025)

5.2 Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Plasma Protease C1-inhibitor Treatment Market Size (2020-2031)

6.2 North America Plasma Protease C1-inhibitor Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2020-2025)

6.4 North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Plasma Protease C1-inhibitor Treatment Market Size (2020-2031)

7.2 Europe Plasma Protease C1-inhibitor Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2020-2025)

7.4 Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size (2020-2031)

8.2 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Plasma Protease C1-inhibitor Treatment Market Size (2020-2031)

9.2 Latin America Plasma Protease C1-inhibitor Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2020-2025)

9.4 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size (2020-2031)

10.2 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Takeda

11.1.1 Takeda Company Details

11.1.2 Takeda Business Overview

11.1.3 Takeda Plasma Protease C1-inhibitor Treatment Introduction

11.1.4 Takeda Revenue in Plasma Protease C1-inhibitor Treatment Business (2020-2025)

11.1.5 Takeda Recent Development

11.2 CSL

11.2.1 CSL Company Details

11.2.2 CSL Business Overview

11.2.3 CSL Plasma Protease C1-inhibitor Treatment Introduction

11.2.4 CSL Revenue in Plasma Protease C1-inhibitor Treatment Business (2020-2025)

11.2.5 CSL Recent Development

11.3 Sanquin

11.3.1 Sanquin Company Details

11.3.2 Sanquin Business Overview

11.3.3 Sanquin Plasma Protease C1-inhibitor Treatment Introduction

11.3.4 Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2020-2025)

11.3.5 Sanquin Recent Development

11.4 Pharming Group

11.4.1 Pharming Group Company Details

11.4.2 Pharming Group Business Overview

11.4.3 Pharming Group Plasma Protease C1-inhibitor Treatment Introduction

11.4.4 Pharming Group Revenue in Plasma Protease C1-inhibitor Treatment Business (2020-2025)

11.4.5 Pharming Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of C1-inhibitors

Table 3. Key Players of Kallikrein Inhibitor (Kalbitor)

Table 4. Global Plasma Protease C1-inhibitor Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Plasma Protease C1-inhibitor Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Plasma Protease C1-inhibitor Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Plasma Protease C1-inhibitor Treatment Market Share by Region (2020-2025)

Table 8. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Plasma Protease C1-inhibitor Treatment Market Share by Region (2026-2031)

Table 10. Plasma Protease C1-inhibitor Treatment Market Trends

Table 11. Plasma Protease C1-inhibitor Treatment Market Drivers

Table 12. Plasma Protease C1-inhibitor Treatment Market Challenges

Table 13. Plasma Protease C1-inhibitor Treatment Market Restraints

Table 14. Global Plasma Protease C1-inhibitor Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Plasma Protease C1-inhibitor Treatment Market Share by Players (2020-2025)

Table 16. Global Top Plasma Protease C1-inhibitor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2024)

Table 17. Ranking of Global Top Plasma Protease C1-inhibitor Treatment Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Plasma Protease C1-inhibitor Treatment, Headquarters and Area Served

Table 20. Global Key Players of Plasma Protease C1-inhibitor Treatment, Product and Application

Table 21. Global Key Players of Plasma Protease C1-inhibitor Treatment, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Plasma Protease C1-inhibitor Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2020-2025)

Table 25. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2026-2031)

Table 27. Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Application (2020-2025)

Table 29. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Application (2026-2031)

Table 31. North America Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 46. Takeda Company Details

Table 47. Takeda Business Overview

Table 48. Takeda Plasma Protease C1-inhibitor Treatment Product

Table 49. Takeda Revenue in Plasma Protease C1-inhibitor Treatment Business (2020-2025) & (US$ Million)

Table 50. Takeda Recent Development

Table 51. CSL Company Details

Table 52. CSL Business Overview

Table 53. CSL Plasma Protease C1-inhibitor Treatment Product

Table 54. CSL Revenue in Plasma Protease C1-inhibitor Treatment Business (2020-2025) & (US$ Million)

Table 55. CSL Recent Development

Table 56. Sanquin Company Details

Table 57. Sanquin Business Overview

Table 58. Sanquin Plasma Protease C1-inhibitor Treatment Product

Table 59. Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2020-2025) & (US$ Million)

Table 60. Sanquin Recent Development

Table 61. Pharming Group Company Details

Table 62. Pharming Group Business Overview

Table 63. Pharming Group Plasma Protease C1-inhibitor Treatment Product

Table 64. Pharming Group Revenue in Plasma Protease C1-inhibitor Treatment Business (2020-2025) & (US$ Million)

Table 65. Pharming Group Recent Development

Table 66. Research Programs/Design for This Report

Table 67. Key Data Information from Secondary Sources

Table 68. Key Data Information from Primary Sources

Table 69. Authors List of This Report

List of Figures

Figure 1. Plasma Protease C1-inhibitor Treatment Picture

Figure 2. Global Plasma Protease C1-inhibitor Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Plasma Protease C1-inhibitor Treatment Market Share by Type: 2024 VS 2031

Figure 4. C1-inhibitors Features

Figure 5. Kallikrein Inhibitor (Kalbitor) Features

Figure 6. Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Plasma Protease C1-inhibitor Treatment Market Share by Application: 2024 VS 2031

Figure 8. Hospital Pharmacies Case Studies

Figure 9. Independent Pharmacies and Outlets Case Studies

Figure 10. Plasma Protease C1-inhibitor Treatment Report Years Considered

Figure 11. Global Plasma Protease C1-inhibitor Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Plasma Protease C1-inhibitor Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Plasma Protease C1-inhibitor Treatment Market Share by Region: 2024 VS 2031

Figure 14. Global Plasma Protease C1-inhibitor Treatment Market Share by Players in 2024

Figure 15. Global Top Plasma Protease C1-inhibitor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue in 2024

Figure 17. North America Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Plasma Protease C1-inhibitor Treatment Market Share by Country (2020-2031)

Figure 19. United States Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Plasma Protease C1-inhibitor Treatment Market Share by Country (2020-2031)

Figure 23. Germany Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Share by Region (2020-2031)

Figure 31. China Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Plasma Protease C1-inhibitor Treatment Market Share by Country (2020-2031)

Figure 39. Mexico Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Share by Country (2020-2031)

Figure 43. Turkey Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Takeda Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2020-2025)

Figure 47. CSL Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2020-2025)

Figure 48. Sanquin Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2020-2025)

Figure 49. Pharming Group Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2020-2025)

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions